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We expressed the y subumt of mouse rod photoreceptor cGMP phosphodiesterase (PDE) m the bacterlal pGEX-2TK cxpresslon vector which 
produces a cleavable 40 kDa fusion protein. The fusion protem can be isolated in a one step procedure by affinity chromatography on glutathione 
beads. The yield of purified fusion protem is approximately 10 mg from 1 liter of bacterlal culture. or about 3 mg of PDEy. equivalent to the PDEy 
content of approximately 200.000 mouse retinas. Both the fusion protein and the cleaved PDEy. to which a short kmase domain remains attached, 
are biologically active, mhibltmg activated PDE m a manner comparable to native PDEy. Immoblhzed PDEy bmds transducm c( subunit charged 
with GTP, PDE a and j? subunits, and, unexpectedly, arrestm (S-antigen). 
Mammalian phototransductlon: Bacterial expression; cGMP phosphodlesterase y subumt 
1. INTRODUCTION 
Rod photoreceptor cGMP phosphodiesterase (PDE) 
consists of 3 subunits termed CI, b, and y according to 
their apparent sizes on SDS gels [l]. The two large 
subunits 01 and/? contain the active site(s) of the enzyme, 
the small subunit, PDEy, is a heat-stable polypeptide 
acting as a inhibitor of activated PDE [2]. PDEy cDNA 
was cloned from bovine [3], mouse [4], and human [5] 
retinal libraries and shown to consist of 87 highly con- 
served residues. PDEy is hydrophilic (24 of its 87 resi- 
dues are charged amino acids). The N-terminal half 
contains all 13 positive charges. while the C-terminal 
half is predominantly negatively charged. Mouse PDEy 
differs from its bovine counterpart by two uncharged 
residues at position 8 and 17 (G,,,,,8Ab,,,,, and 
I mOuSe17M,,,,.,,,) which do not influence biological prop- 
erties [6]. Apart from N-terminal acetylation [3] no 
other post-translational processing has been shown to 
occur. Bovine PDEy was expressed in bacteria using a 
synthetic template in a vector which produced a biolog- 
ically active, cleavable fusion protein consisting of 7 
amino acid residues of the C-terminal end of the clotting 
protease factor Xa [7] and PDEy (~11~). Mouse PDEy 
was expressed as a noncleavable fusion protein Cggaly) 
in the bacterial vector pUC19 [6]. Both procedures are 
relatively tedious requiring column chromatography for 
purification of the respective fusion proteins. Moreover, 
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transformed bacterial strains expressing cIIy are unstable 
PI, 
As part of our effort to express an active mouse PDE 
holoenzyme in bacteria [9] or insect cells infected with 
recombinant baculovirus [lo], we have cloned mouse 
PDEy cDNA into the expression vector pGEX-2TK 
[l 11. This vector construct produces a large fusion pro- 
tein (40 kDa) consisting of 26 kDa of the C-terminal end 
of glutathione-S-transferase (GST), a thrombin cleav- 
age site. an adapter (K) suitable for phosphorylation by 
protein kinases, and the 87 residues of mouse PDEy. 
The expressed fusion protein, termed GK-PDEy, can be 
rapidly isolated in large amounts by affinity chromatog- 
raphy on glutathione beads, and cleaved by thrombin 
to produce K-PDEy (PDEy to which the kinase domain 
remains attached). In this paper we describe the expres- 
sion and isolation of GK-PDEy (40 kDa) and K-PDEy 
(14kDa) and show that both products are biologically 
active. 
2. MATERIALS AND METHODS 
2.1. E.yore.won vector 
Mouse PDEy cDNA was amplified with PfuI thermostable DNA 
polymerase (Stratagene) on first strand retinal cDNA template using 
a N-terminal sense primer 5’.AAT TGG ATC CCT CAT GAA CCT 
GGA GCC ACC CAA GGG TG and a C-terminal antisense primer 
5’-AAT CGA TCC GAG CTC TAG ATG ATG CCG TAC TGG _- 
GCC The primers Include translation start and stop codons (under- 
lined) of PDEy and introduce BumHI clonmg sites (bold-faced). A 278 
bp BtinlHI fragment was cloned mto pBluescrlpt and completely se- 
quenced. The DNA sequence was ldentlcal to the published sequence 
[4] except for codon 35 (ACA vs. ACC) which does not alter the 
predicted ammo acid sequence. The 278 bp L&zHI fragment was filled 
m with dNTP/Klenow and cloned mto the filled-in Btir,lHI site of the 
expresslon vector pGEX-1TK (generous gift of Dr. W. Kaehn. Dana 
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Farber Cancer Center, Boston, MA). The correctness of the reading 
frame was confirmed by DNA sequencing with PDEy specific primers. 
The recombinant plasmid, pGEX-2TKy. was transformed into 
BL21DE3 stram (Novagen), and several transformants grown m over- 
night cultures consistmg of 50 @ml ampicillin in LB broth. 
2.2. Isolation of GK-PDEy and K-PDEy 
The fusion protein was isolated by a procedure described by Smith 
and Johnson [ll], as modrfied by Kaelin [12]. Briefly, an overnight 
culture was diluted lo-fold with LB/Amp, grown for an additional 
hour, and induced wrth 0.2 mM IPTG for two hours. Bacteria were 
spun down at 5 000 rpm/lO mm (GSA rotor, sorvall), suspended in 
NETN buffer (0.5% NP-40. 1 mM EDTA. 20 mM Tris-HCl pH 8.0, 
100 mM NaCI), lysed by somcation, and the lysed cells centrifuged at 
12 000 rpm/20 mm (SA600 rotor, Sorvall). The msoluble pellet was 
treated with 8 M urea at room temperature for 30 min. and the 
solution dialyzed against lysis buffer. The dialysate was incubated with 
glutathione agarose beads (Sigma) for 30 min. The fusion protein was 
released from the beads by 2 treatments with 5 bead volumes each of 
20 mM glutathione in 50 mM Trrs-HCl pH 8.0 and 100 mM NaCl(30 
min/4”C). The eluate containmg the fusion protein was dialyzed 
against 50 mM Tris-HCl pH 8.0,O. 1 M NaCI. 50% glycerol, and stored 
at -20°C. Protem concentrations were determined according to 
Bradford [13]. K-PDEy was isolated by Incubating 10 pg GK-PDEy 
with 2 ~1 of human thrombm (Sigma, approx. 1 U/PI protem) in 50 
mM Tris pH7 0, 150 mM NaCl. 2.5 mM CaCl: at room temperature 
for 1 h. The digestion was followed by boihng for 4 min and centrifu- 
gation (10 min. 15 000 x g). The supernatant, containing K-PDEy was 
used for SDS-PAGE and PDE inhibition. 
2.3. Bmding retinul po!l;oeptrdes to wumobilced GK-PDEy 
Two bovine retinas (bleached) were homogenized twice in 2 ml each 
of hypotonic buffer (20 mM Tris, 0.1 mM DTT, 0.1 mM EDTA) 
containing GTPyS (2 PM) and PMSF (0.5 PM). The homogenates 
were spun at 15 000 x g for 15 min. and the supernatants were com- 
bmed. To 200 ~1 of supernatant. 25 ~1 of 10 x isotonic buffer [I] and 
20 ~1 glutathione agarose beads charged with GK-PDEy were added 
The suspension was kept at 4°C for 30 min. spun at 3 000 xg for 2 min, 
the supernatant discarded and the beads washed with 1 ml isotonic 
buffer three times. To the final washed pellet, 20~1 SDS sample buffer 
was added, mixed. and a 5 ~1 aliquot was used for SDS-PAGE. 
2.4. PDE assqx 
PDE activity was assayed [14] by recording the release of protons 
with a pH microelectrode (MI-410, Mrcroelectrodes. Inc.). The pH 
assay buffer contained 20 mM MOPS pH 8.0, 0.15 M KCI. 2 mM 
MgCl,. cGMP was added to final concentration of 2 mM [15]. the final 
volume was 200 PI. 
2.5. Isolation of tramdun subunits. PDE. arrestin 
Transducm a subunit was eluted from ROS membranes in the pres- 
ence of 2 PM GTPyS m isotonic buffer. Bovine PDE was isolated as 
described earlier [16]. Purified arrestm, a generous gift of Dr. Abdallah 
J. Ghalayini (Baylor College of Medrcme). was isolated according to 
Wilden et al. [17,18]. 
3. RESULTS AND DISCUSSION 
3.1. Production and Isolation of GK-PDEy and K- 
PDEy 
PDEy is present in rod photoreceptors in minute 
amounts, tightly bound to the PDE large subunits with 
a KD (measured in bovine) of less than 10 pM [15]. To 
facilitate its isolation from bacterial cultures, we ex- 
pressed mouse PDEy as a fusion protein using the GST- 
2KT expression vector [l l] (Fig. 1). This vector pro- 
vides an N-terminal GST domain for rapid isolation of 
the product by affinity chromatography, a thrombin 
cleavage site (T) which allows removal of GST, and a 
kinase domain (K) which may be used to phosphorylate 
and label PDEy. Induced by IPTG, the fusion protein 
is overexpressed and accumulates to about 10 mg/ liter 
of bacterial culture (Fig. 2, lane 4), corresponding to 
about 3 mg of K-PDEy. Most of the fusion protein is 
stored in insoluble inclusion bodies (Fig. 2, lane 6), from 
which it may be released by treatment with 8 M urea 
(lane 7). The purified fusion product GK-PDEy (lane 
9), after digestion with thrombin, is cleaved into the 
GST component and K-PDEy (lane 10). Taking advan- 
tage of the heat stability of PDEy, K-PDEy may be 
isolated from this mixture in purified form after a short 
boiling step and centrifugation (lane 11). K-PDEy is 
pGEX=2TKy 
pGEX-2TK 
,3Obp , / 
. . . LVPRGSRRASVGS 
f 
I L M . . . 
thrombin kinase - domain 
T K 
Fig. 1. Schematic representation of the expression vector construct. Upper part: schematic of the expression vector pGEX-2TKy. The interrupted 
white box symbolizes the 26 kDa GST fragment, the strppled boxes depict the adapter containing the thrombin cleavage and protein kinase domain. 
PDEy cDNA is shown as a large black box, and the cloning vector, pGEX-2TK, as open ended hatched boxes. Lower part: DNA and amino acid 
sequences of the adapter between the GST leader and PDEy. The thrombin cleavage site (T) is marked by an arrow, and the kinase domain (K) 
IS boxed. The 4 amino acid residues GSIL between the kinase domain and PDEy are the result of in-frame cloning (ligation of two blunt-ended 
BumHI sites, identified as (B) and underlined). 
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Fig. 2. SDS-PAGE/Western blot of purificatron of GK-PDEy and K-PDEy A, stages of purification of GK-PDEy. Lane 1 and 2, proteins 
expressed by the expression vector pGEX-2TKy. before (-) and after (+) Induction wrth IPTG. respectively. Lane 3, 4: proteins expressed by 
pGEX-2TKy, before (-) and after (+) induction. The arrow points to the GK-PDEy fusron protein (40 kDa). Lane 5, supernatant. and lane 6, 
pellet of a 100 ml bacterial suspension lysed in SDS buffer. Lane 7, pellet after solubrlization in 8 M urea. Lane 8, molecular weight markers (see 
Fig. 5, lane 4). Lane 9. materral bound to glutathione beads. Lane 10, the fusion protein GK-PDEy eluted from the beads and cleaved wrth thrombin. 
The upper band is the GST leader, the lower band is K-PDEy Lane 11, purified K-PDEy after boilmg of the cleaved materral in lane 10 for 4 
min. B, Western blot. Lane 1, GK-PDEy (lane 9 of A) product Lane 2, K-PDEy (lane 11 of A). 
stable in a solution of 50% glycerol at -20°C for at least 
one month. 
3.2. GK-PDEy und K-PDEy inhibit activated cGMP 
PDE 
Activation of PDE holoenzyme (@yz) in vivo is 
achieved by the transducin a subunit charged with GTP, 
T GTP [19], involving physical removal or dislocation of 
PDEy by a still unknown mechanism [8,20]. Limited 
trypsinolysis of PDE holoenzyme destroys the inhib- 
itory PDEy subunit, and generates a highly active PDE 
core enzyme PDE@ in vitro [2]. To demonstrate inhib- 
itory activity of the expressed fusion product, PDEo$ 
was augmented with excess of GK-PDEy, K-PDEy, 
and the GST component without y as a control. and 
hydrolysis of cGMP was monitored with a pH electrode 
[14]. As shown in Fig. 3, GST has little effect on PDE 
activity (trace I), when compared with a control (c). In 
contrast, both GK-PDEy and K-PDEy completely in- 
hibit hydrolysis of cGMP (traces 2 and 3) consistent 
with the localization of the inhibitory domain of PDEy 
at the C-terminus [8,21-231 which is unaffected by the 
addition of GK. Addition of equal amounts of trypsin 
(arrow) destroys GK-PDEy and K-PDEy and restores 
activity. Restoration of activity from GK-PDEyl 
PDE@ (trace 3) was significantly slower than from 
K-PDEyIPDEQ, possibly due to the size of GK-PDEy 
(40 kDa) which is four times larger than K-PDEy (10 
8 
kDa). Addition of more trypsin to PDEolplGK-PDEy 
increases the rate of cGMP hydrolysis (not shown). The 
results show that both the fusion protein and K-PDEy 
inhibit activated PDE in a fashion comparable to native 
PDEy. 
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Ftg. 3. Inhtbrtion of cGMP PDE activity by GK-PDEy and K-PDEy. 
Trace (c). trypsin-activated bovine PDE as a control. The base-line 
was recorded for 90 s. then cGMP was added to a final concentration 
of 2 mM (at arrow marked ‘cGMP’) to start the cGMP hydrolyses. To 
trypsmized bovine PDE, purified GST (trace l), K-PDEy (trace 2). 
and GK-PDEy (trace 3), were added. An ahquot of trypsin (at arrow 
marked ‘trypsin’) was added to traces 2 and 3 to reverse inhibition. 
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Fig. 4. Bmding of retinal components to tmmobilized GK-PDEy. A, bindmg of polypeptides present in retina lysates to glutathione beads containing 
GK-PDEy. Lane 1, GST beads; lane 2, GST beads equihbrated with retina lysate; lane 3, GK-PDEy-beads: lane 4, GK-PDEy beads equihbrated 
wtth retina lysate Polypeptides bound are labeled a (large PDE subunits), p (arrestin), and c (transducm a subunit). Lane 5, molecular weight 
markers. B, Western blot of A2 (lane 1) and A4 (lane 2) probed wnh a PDE specific polyclonal anttbody (MOE). Lane 3, bovine PDE large subunits 
as a control. C, Western blot of A2 (lane l), and A4 (lane 2) probed wtth transducin a subumt antibody. Purified transducin is shown in lane 3. 
D. Western blot of A2 (lane I) and A4 (lane 2) probed wrth arrestin specific anttbody. 
3.3. Immobilized GK-PDEy binds transducin a subunit 
charged with GTP, PDE large subunits and arrestin 
Apart from inhibition of activated PDE, the biologi- 
cal activity of PDEy also consists of interaction with 
T GTP, To demonstrate that the expressed fusion protein 
isa biologically active, we exposed immobilized GK- 
PDEy to bovine retinal extracts containing components 
soluble in hypotonic buffer containing 2 ,uM GTPyS 
(Fig. 4). A control experiment with GST (mobility 30 
kDa) indicates binding of two unidentified proteins of 
a molecular weight lower than 30 kDa. Immobilized 
GK-PDEy. but not the GST component, binds three 
retinal components termed a, b, c (Fig. 4A, lane 4) of 
the mobilities 40K, 50K, and 90K, respectively. The 
90K component (a) was identified by its antigenicity to 
a polyclonal antibody (MOE, Fig. 4B) as the PDE large 
subunits (which do not separate in the gel system used 
in Fig. 4). Binding of the PDE large subunits is pre- 
sumed to be due to the replacement of the endogenous 
y subunit by immobilized GK-PDEy [24]. The multiple 
antigenic bands in Fig 4B, lane 2 are presumably degra- 
dation products of GK-PDEy which is exposed to var- 
ious PMSF-insensitive proteases present in the hypo- 
tonic retinal extract. The 40K component (c) was iden- 
tified as transducin a subunit in a Western blot with a 
T, specific antibody (Fig. 4C). The transducin p subunit 
does not bind under these conditions, and the a subunit 
only binds to immobilized GK-PDEy when eluted from 
ROS membranes in the presence of GTPyS (not 
shown). Thus, the expressed GK-PDEy, by virtue of its 
inhibition of activated PDE and binding of its activator 
and the large subunits of PDE, is biologically active. 
The 50K polypeptide (b) was identified as arrestin 
(48K protein, S-antigen) again by Western blotting of 
lane 4 (Fig. 4A) and probing with an anti-arrestin poly- 
clonal antibody. The binding of arrestin to immobilized 
PDEy was independent of ATP (1 mM), and tight 
enough to survive three stringent washings with isotonic 
buffer (see section 2). Purified TaCTP and PDE inde- 
pendently bind to immobilized PDEy (not shown). The 
binding of purified arrestin, in the absence of transducin 
and PDE, to immobilized PDEy is shown in Fig. 5. 
These results indicate that binding of the three individ- 
ual components is independent from the presence of any 
of the other two. 
3.4. Putative role of arrestin 
The binding of arrestin, which is thought to quench 
PDE activation by binding to phosphorylated rhodop- 
sin [l&25,26] thus inhibiting the generation of the PDE 
activator TaGTP, is surprising since no definitive role of 
arrestin downstream of rhodopsin in the pho- 
totransduction cascade has been established. It has been 
reported, however, that arrestin may have the ability to 
directly act on PDE, inhibiting its activation by TaGTP 
[27,28]. The term ‘arrestin’, in fact, was coined for 48K 
protein’s proposed role as a deactivator of phosphodi- 
esterase [27]. It is conceivable that arrestin may bind to 
PDE holoenzyme via its y subunit, with possible points 
of contact also on the large PDE subunits, and that 
T GTP may be unable to displace PDEy and activate 
PDE. Although other laboratories have been unable to 
confirm a direct action of arrestin on PDE [18,26,29], 
our results clearly show that PDEy can interact with 
9 
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Fig. 5. Equilibration of GST and GK-PDEy beads with purified 
arrestin. Glutathione beads charged with GST (lane 1). GK-PDEy 
(lane 2) were incubated wtth purtfied arrestm (lane 3) as described m 
Fig. 4. Lane 5. molecular weight markers, 
arrestin. A shared domain of sequence homology near 
the C-termini of T, and arrestin [30] may participate in 
binding to sites on PDEy [31,32]. A final analysis of a 
possible role of arrestin on modulation of PDE will 
have to await a more quantitative evaluation of the 
interaction of the components. 
Acknowledgements The expression vector contaming the kmase do- 
main was kindly provided by Dr. W. Kaelm (Dana Farber Cancer 
Center, Boston). The polyclonal anti-PDE antibody used m this study 
was obtained from Dr. Bernard K.K. Fung (UCLA), the T, specific 
antibody from Dr. Ted Wensel (Baylor College of Medicine). and the 
arrestm antibody from Dr. Abdallah J. Ghalaymi (Baylor College of 
Medicine). We thank Dr. Theodore Wensel for expert advice in setting 
up the pH electrode assay, and for critically readmg this manuscrtpt 
This investigation was supported by grants from the National Eye 
Institute (EY08123). the National Retimtis Pigmentosa Foundation. 
the Gund Foundation, and the Retma Research Foundation (Hous- 
ton) to W B; N.Q. is supported as a predoctoral fellow by a center 
grant of the National Retmttis Pigmentosa Foundation to the Depart- 
ment of Ophthalmology; W.B. is the recipient of a Jules and Doris 
Stem Research to Prevent Blindness Professorship (Research to Pre- 
vent Blindness, Inc., Bahtmore). 
REFERENCES 
[l] Baehr, W.. Devhn. M.J. and Applebury. M L. (1979) J. Biol. 
Chem. 254. 11669-11677. 
[4 
[31 
[41 
(51 
Kl 
[71 
PI 
[91 
[lOI 
Pll 
[121 
u31 
[I41 
u51 
[I61 
u71 
U81 
u91 
WI 
Fll 
P21 
P31 
P41 
~251 
PI 
~271 
P.31 
1’91 
[301 
[311 
1321 
Hurley. J B. and Stryer. L. (1982) J Biol. Chem. 257, 11094 
11099. 
Ovchmnikov, Y A.. Lipkm, V.M., Kumarev. V.P.. Gubanov. 
V V.. Khramtsov. N V., Akhmedov. N.B.. Zagranichny, V E. 
and Muradov. K G. (1986) FEBS Lett. 204, 2888292. 
TuteJa. N and Farber. D.B. (1988) FEBS Lett. 232, 1822186. 
Tuteja, N., Danciger. M.. Khsak. 1.. TuteJa, R., Inana, G., Mo- 
handas, T., Sparkes. R.S. and Farber, D.B. (1990) Gene 88, 
2277232. 
Griswold-Prenner, I., TuteJa. N., Farber. D.B. and Fung, B.K.- 
K. (1989) Biochemistry 28. 61456150. 
Brown, R.L. and Stryer, L ( 1989) Proc. Nat1 Acad. Sci. USA 
86. 49324926. 
Brown, R L. (1992) Biochemistry 31. 5918-5925. 
Qm. N.. Pntler. S J. and Baehr, W (1992) J. Biol. Chem. 267, 
8458-8463. 
Qm, N and Baehr. W. (1992) Invest. Ophthalmol Vis. Sci. 33, 
1005. 
Smith, D.B. and Johnson. KS. (1988) Gene 67. 3140. 
Kaelin Jr., W.G., Pallas, D.C.. DeCaprto. J.A., Kaye. F.J. and 
Livingston D.M. (1991) Cell 64. 521-532. 
Bradford, M.M. (1976) Anal. Biochem 72. 2488254. 
Liebman, P.A. and Evanczuk. T. (1982) Methods Enzymol. 81. 
5322542. 
Wensel. T.G and Stryer. 1. (1986) Prot. Struct Funct Genet. 1, 
90-99. 
Baehr. W.. Morna. E.. Swanson, R and Applebury. M.L. (1982) 
J. Biol. Chem. 257, 645226460. 
Kuhn, H.. Hall. S.W and Wilden. U. (1984) FEBS Lett. 176, 
4733478. 
Wilden. U.. Hall, SW. and Kuhn, H (1986) Proc. Nat1 Acad. 
Sci. USA 83, 11741178 
Fung. B.K.-K.. Hurley, J G. and Stryer. L. (1981) Proc. Natl. 
Acad. %I. USA 78, 152-156. 
Clerc, A. and Bennett, N (1992) J. Btol Chem. 267.6620-6627. 
Lipkm. V.M . Dumler, I L.. Muradov, K.G.. Artemyev. N 0. 
and Etmgof, R.N. (1988) FEBS Lett. 734. 2877290 
Takemoto, D.J . Hurt. D.. Oppert. B. and Cunmck, J. (1992) 
Biochem. J 281. 637-643 
Ltpkm. V M.. Udovlchenko, I.P.. Bondarenko. V.A., 
Yurovskaya, A.A.. Telnykh. E.V. and Skiba, N.B. (1990) Bi- 
omed. SCI. 1, 3055313. 
Wensel, T.G. and Stryer, L. (1990) Biochemistry 29. 2155-2161 
Thnkill. C.E., Tait. R.C., Tyler. N.K.. Roth, A.M , and Keltner, 
J.L. (1992) Invest. Ophthalmol Vis SCI. 33. 276882772. 
Palczewski. K . Rtspoh. G. and Detwiler. P B. (1992) Neuron 8, 
117-126. 
Zuckerman, R. and Cheasty. J.E (1986) FEBS Lett. 207. 3541. 
Zuckerman, R. and Cheasty, J.E. (1988) FEBS Lett 238. 3799 
384. 
Palczewski, K.. Pulvermdller. A., Buczylko, J. and Hofmann. 
K.P. (1991) J. Biol. Chem. 266, 18649918654. 
Yamakr. K.. Tsuda, M and Shinohara. T (1988) FEBS Lett. 234, 
3943. 
Artemyev. N.O., Rarick. H.M., Mills. J.S.. Skiba. N P. and 
Hamm. H E (1992) J. B~ol. Chem. 267, 25067725072. 
Rarick. H.M.. Artemyev. N.O. and Hamm. H.E. (1992) Science 
256. 1031~1033 
10 
